Association between maternal chronic conditions and congenital heart defects: A population-based cohort study

Circulation

Volumn 128, Issue 6, 2013, Pages 583-589

  Liu, Shiliang ^a,b   Joseph, K S ^d   Lisonkova, Sarka ^c   Rouleau, Jocelyn ^a   Van Den Hof, Michiel ^e   Sauve, Reg ^f   Kramer, Michael S ^g  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e DALHOUSIE UNIVERSITY   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

^g MCGILL UNIVERSITY   (Canada)

Author keywords

epidemiology; etiology; heart defects, congenital; maternal fetal relations

Indexed keywords

ADULT; ANEMIA; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; ATRIOVENTRICULAR SEPTAL DEFECT; CANADA; CHILD HOSPITALIZATION; CHRONIC DISEASE; COHORT ANALYSIS; COMPLEX DEFECT; CONGENITAL HEART DISEASE; CONGENITAL HEART MALFORMATION; CONNECTIVE TISSUE DISEASE; CONOTRUNCAL DEFECT; DISEASE ASSOCIATION; DISEASE SEVERITY; EPILEPSY; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE SEPTUM DEFECT; HETEROTAXY SYNDROME; HOSPITAL READMISSION; HUMAN; ICD-10; INFANT; LIVE BIRTH; LUNG VEIN DRAINAGE ANOMALY; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MATERNAL DISEASE; MATERNAL HYPERTENSION; MOOD DISORDER; MOTHER FETUS RELATIONSHIP; MULTIPLE PREGNANCY; PARITY; PATENT DUCTUS ARTERIOSUS; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RESIDENTIAL AREA; SYSTEMIC DISEASE; THYROID DISEASE;

EPIDEMIOLOGY; ETIOLOGY; HEART DEFECTS, CONGENITAL; MATERNAL-FETAL RELATIONS;

ADULT; CANADA; CHRONIC DISEASE; COHORT STUDIES; CONNECTIVE TISSUE DISEASES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DOWN SYNDROME; EPILEPSY; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION; INFANT, NEWBORN; MALE; MOOD DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY, MULTIPLE; RISK FACTORS; THYROID DISEASES; YOUNG ADULT;

EID: 84881131100     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.001054     Document Type: Article

References (41)

1. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890-1900.
2. Oyen N, Poulsen G, Boyd HA, Wohlfahrt J, Jensen PK, Melbye M. National time trends in congenital heart defects, Denmark, 1977-2005. Am Heart J. 2009;157:467-473.e1.
3. Health Canada. Congenital Anomalies in Canada: Perinatal Health Report, 2002. Ottawa, ON, Canada: Minister of Public Works and Government Services Canada; 2002.
4. Reller MD, Strickland MJ, Riehle-Colarusso T, Mahle WT, Correa A. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr. 2008;153:807-813.
5. Liu S, Joseph KS, Wen SW. Trends in fetal and infant deaths due to congenital anomalies. Semin Perinatol. 2002;26: 268-276.
6. Liu S, Joseph KS, Wen SW, Kramer MS, Marcoux S, Ohlsson A, Sauve R. Secular trends in congenital anomaly-related fetal and infant mortality in Canada, 1985-1996. Am J Med. Genet. 2001;104:7-13.
7. Dolk H, Loane M, Garne E; European Surveillance of Congenital Anomalies (EUROCAT) Working Group. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation. 2011;123:841-849.
8. Dadvand P, Rankin J, Shirley MD, Rushton S, Pless-Mulloli T. Descriptive epidemiology of congenital heart disease in Northern England. Paediatr Perinat Epidemiol. 2009;23:58-65.
9. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation. 2007;115:163-172.
10. Gurvitz MZ, Inkelas M, Lee M, Stout K, Escarce J, Chang RK. Changes in hospitalization patterns among patients with congenital heart disease during the transition from adolescence to adulthood. J Am Coll Cardiol. 2007;49:875-882.
11. Warnes CA, Liberthson R, Danielson GK, Dore A, Harris L, Hoffman JI, Somerville J, Williams RG, Webb GD. Task Force 1: the changing profile of congenital heart disease in adult life. J Am Coll Cardiol. 2001;37:1170-1175.
12. Botto LD, Lin AE, Riehle-Colarusso T, Malik S, Correa A; National Birth Defects Prevention Study. Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol. 2007;79:714-727.
13. Williams LJ, Correa A, Rasmussen S. Maternal lifestyle factors and risk for ventricular septal defects. Birth Defects Res A Clin Mol Teratol. 2004;70:59-64.
14. Tikkanen J, Heinonen OP. Risk factors for cardiovascular malformations in Finland. Eur J Epidemiol. 1990;6:348-356.
15. Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels, SR, Elixson M, Warnes CA, Webb CL; American Health Association Council on Cardiovascular Disease in the Young. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young. Circulation. 2007;115:2995-3014.
16. Wilson PD, Loffredo CA, Correa-Villaseñor A, Ferencz C. Attributable fraction for cardiac malformations. Am J Epidemiol. 1998;148: 414-423.
17. Czeizel AE. Periconceptional folic acid containing multivitamin supplementation. Eur J Obstet Gynecol Reprod Biol. 1998;78:151-161.
18. Morrison HI, Schaubel D, Desmeules M, Wigle DT. Serum folate and risk of fatal coronary heart disease. JAMA. 1996;275:1893-1896.
19. Ferencz C, Loffredo CA, Correa-Villasenor A, Wilson PD. Genetic and Environmental Risk Factors of Major Cardiovascular Malformations: The Baltimore-Washington Infant Study 1981-1989. Armonk, NY: Futura Publishing Co; 1997.
20. Ray JG, O'Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. QJM. 2001;94:435-444.
21. Public Health Agency of Canada. Canadian Perinatal Health Report, 2008 Edition. 2008. http://www.phac-aspc.gc.ca/publicat/2008/cphr-rspc/pdf/cphr- rspc08-eng.pdf, Accessed May 13, 2013.
22. Joseph KS, Kinniburgh B, Hutcheon JA, Mehrabadi A, Basso M, Davies C, Lee L. Determinants of increases in stillbirth rates from 2000 to 2010. CMAJ. 2013;185:E345-E351.
23. Liu S, Heaman M, Joseph KS, Liston RM, Huang L, Sauve R, Kramer MS; Maternal Health Study Group of the Canadian Perinatal Surveillance System. Risk of maternal postpartum readmission associated with mode of delivery. Obstet Gynecol. 2005;105:836-842.
24. Canadian Institute for Health Information. In Due Time: Why Maternal Age Matters. 2011. www.cihi.ca. Accessed May 13, 2013.
25. Kramer MS, Rouleau J, Liu S, Bartholomew S, Joseph KS; Maternal Health Study Group of the Canadian Perinatal Surveillance System. Amniotic fluid embolism: incidence, risk factors, and impact on perinatal outcome. BJOG. 2012;119:874-879.
26. van der Bom T, Zomer AC, Zwinderman AH, Meijboom FJ, Bouma BJ, Mulder BJ. The changing epidemiology of congenital heart disease. Nat Rev Cardiol. 2011;8:50-60.
27. Ferencz C, Rubin JD, Loffredo C, Magee C. Epidemiology of Congenital Heart Disease: The Balimore-Washington Infant Study 1981-1989. Armonk, NY: Futura Publishing Co; 1993.
28. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health. 1998;88:15-19.
29. Liu S, Joseph KS, Kramer MS, Allen AC, Sauve R, Rusen ID, Wen SW; Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System. Relationship of prenatal diagnosis and pregnancy termination to overall infant mortality in Canada. JAMA. 2002;287:1561-1567.
30. Bull C. Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. British Paediatric Cardiac Association. Lancet. 1999;354:1242-1247ik.
31. Ooshima A, Fukushige J, Ueda K. Incidence of structural cardiac disorders in neonates: an evaluation by color Doppler echocardiography and the results of a 1-year follow-up. Cardiology. 1995;86:402-406.
32. Roguin N, Du ZD, Barak M, Nasser N, Hershkowitz S, Milgram E. High prevalence of muscular ventricular septal defect in neonates. J Am Coll Cardiol. 1995;26:1545-1548.
33. Germanakis I, Sifakis S. The impact of fetal echocardiography on the prevalence of liveborn congenital heart disease. Pediatr Cardiol. 2006;27:465-472.
34. Abu-Sulaiman RM, Subaih B. Congenital heart disease in infants of diabetic mothers: echocardiographic study. Pediatr Cardiol. 2004;25:137-140.
35. Nielsen GL, Nørgard B, Puho E, Rothman KJ, Sørensen HT, Czeizel AE. Risk of specific congenital abnormalities in offspring of women with diabetes. Diabet Med. 2005;22:693-696.
36. Lisowski LA, Verheijen PM, Copel JA, Kleinman CS, Wassink S, Visser GH, Meijboom EJ. Congenital heart disease in pregnancies complicated by maternal diabetes mellitus: an international clinical collaboration, literature review, and meta-analysis. Herz. 2010;35:19-26.
37. Mikhail LN, Walker CK, Mittendorf R. Association between maternal obesity and fetal cardiac malformations in African Americans. J Natl Med Assoc. 2002;94:695-700.
38. Watkins ML, Botto LD. Maternal prepregnancy weight and congenital heart defects in offspring. Epidemiology. 2001;12:439-446.
39. Källén K. Maternal smoking and congenital heart defects. Eur J Epidemiol. 1999;15:731-737.
40. Woods SE, Raju U. Maternal smoking and the risk of congenital birth defects: a cohort study. J Am Board Fam Pract. 2001;14:330-334.
41. Ionescu-Ittu R, Marelli AJ, Mackie AS, Pilote L. Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada. BMJ. 2009;338:b1673.